Trial intelligence / Profile preview

Transdermal buprenorphine dose comparison for postoperative pain after laparotomic hysterectomy

2008-003946-28Phase 3Terminated

Sponsor
IRCCS Burlo Garofolo
Start
Mar 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of buprenorphine in postoperative pain (3 arms), sponsored by IRCCS Burlo Garofolo. Primary endpoints: Primary efficacy responder endpoint and Rescue medication consumption. Started Mar 2009; status: terminated.

02

Drugs

buprenorphine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2008-003946-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-003946-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call